Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration	eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 1	2025-02-07		NCT06132035

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Caregen Co. Ltd.	1
CBCC Global Research	6

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials